1. Home
  2. BOLD vs KSCP Comparison

BOLD vs KSCP Comparison

Compare BOLD & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • KSCP
  • Stock Information
  • Founded
  • BOLD 2018
  • KSCP 2013
  • Country
  • BOLD United States
  • KSCP United States
  • Employees
  • BOLD N/A
  • KSCP N/A
  • Industry
  • BOLD
  • KSCP Telecommunications Equipment
  • Sector
  • BOLD
  • KSCP Telecommunications
  • Exchange
  • BOLD Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • BOLD 24.4M
  • KSCP 35.9M
  • IPO Year
  • BOLD 2024
  • KSCP 2022
  • Fundamental
  • Price
  • BOLD $1.19
  • KSCP $5.59
  • Analyst Decision
  • BOLD Buy
  • KSCP Strong Buy
  • Analyst Count
  • BOLD 3
  • KSCP 3
  • Target Price
  • BOLD $4.00
  • KSCP $15.67
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • KSCP 1.0M
  • Earning Date
  • BOLD 08-11-2025
  • KSCP 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • KSCP N/A
  • EPS Growth
  • BOLD N/A
  • KSCP N/A
  • EPS
  • BOLD N/A
  • KSCP N/A
  • Revenue
  • BOLD N/A
  • KSCP $11,468,000.00
  • Revenue This Year
  • BOLD N/A
  • KSCP $16.17
  • Revenue Next Year
  • BOLD N/A
  • KSCP $39.02
  • P/E Ratio
  • BOLD N/A
  • KSCP N/A
  • Revenue Growth
  • BOLD N/A
  • KSCP N/A
  • 52 Week Low
  • BOLD $1.00
  • KSCP $2.45
  • 52 Week High
  • BOLD $4.72
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • KSCP 40.74
  • Support Level
  • BOLD N/A
  • KSCP $7.30
  • Resistance Level
  • BOLD N/A
  • KSCP $10.14
  • Average True Range (ATR)
  • BOLD 0.00
  • KSCP 0.97
  • MACD
  • BOLD 0.00
  • KSCP -0.31
  • Stochastic Oscillator
  • BOLD 0.00
  • KSCP 1.09

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: